Medical Device & MedTech Layoffs in 2025: A Roundup

In 2025, as market pressures intensify and companies refocus on core strategic priorities, medical device and medtech companies have been forced to make tough decisions regarding their workforces.

These developments come amid a broader nationwide trend of workforce realignment, with both private and public entities, including the FDA’s recent rehires amid mass layoffs, adapting to ongoing pressures.

It is important to note that the medtech landscape has experienced major layoffs in previous years as well. In 2024, GRAIL reduced its workforce by 30% as part of a corporate restructuring to focus on its core multi-cancer early detection business, while BD (Becton Dickinson) cut 200 jobs at its Israeli manufacturing plant amid efforts to streamline operations.

Medtronic, one of the world’s largest medtech companies, also announced significant workforce reductions in 2024.

These examples serve as reminders that workforce adjustments are an ongoing trend in the industry.

This roundup will cover layoffs in the US throughout 2025, spotlighting both finalized and planned reductions in staff.

Whether driven by leadership changes, restructuring efforts or shifts in market demand, these adjustments underscore the evolving landscape in medtech.

In this Xtalks blog, readers can expect to find key coverage from leading medtech companies, including established industry giants and emerging innovators.

Hyperfine Layoffs 2025

Hyperfine reduced its workforce by 18 positions in late January 2025. The cuts, mainly affecting technical staff, support its shift from product development toward a commercialization phase.

Acutus Medical Layoffs 2025

Acutus Medical cut approximately 115 positions — about 70% of its workforce — in response to a strategic partnership with Medtronic, aimed at reducing operating costs and streamlining its cardiac device operations.

Illumina Layoffs 2025

Illumina plans to eliminate 96 positions at its San Diego headquarters between April and August 2025. This targeted reorganization is designed to align resources with its core genomics priorities.

Staar Surgical Layoffs 2025

Staar Surgical has announced plans to cut 115 positions, effective April 21, 2025, primarily at its Monrovia, CA facility, in response to a slowdown in market demand, especially in China.

Cepheid Layoffs 2025

Cepheid, a molecular diagnostics company, is laying off 167 employees across its California sites due to decreased demand for its COVID-19 tests.

Solventum Layoffs 2025

Solventum, a spinoff from 3M, is eliminating 800 positions, including 110 in Minnesota, as part of a restructuring plan aimed at saving $120 million annually.